Pharma Mar, S.A.

BMV:PHM1 N Stock Report

Market Cap: Mex$11.2b

Pharma Mar Management

Management criteria checks 1/4

Pharma Mar's CEO is Jose Maria Fernandez Sousa-Faro, appointed in Jan 1986, has a tenure of 37.42 years. directly owns 6.15% of the company’s shares, worth MX$687.54M. The average tenure of the management team and the board of directors is 10.3 years and 1.7 years respectively.

Key information

Jose Maria Fernandez Sousa-Faro

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure37.4yrs
CEO ownership6.1%
Management average tenure10.3yrs
Board average tenure1.7yrs

Recent management updates

Recent updates

CEO

Jose Maria Fernandez Sousa-Faro

37.4yrs

Tenure

€294,000

Compensation

Mr. José María Fernández Sousa-Faro, Ph D., founded Pharma Mar, S.A.U. in 1986. He Founded Noscira, S.A., in 2000.He serves as the Chief Executive Officer and President of Pharma Mar, S.A.U. He serves as...

Leadership Team

NamePositionTenureCompensationOwnership
Jose Maria Fernandez Sousa-Faro
Founder37.4yrs€294.00k6.15%
MX$ 687.5m
Pedro Fernandez Puentes
Executive Vice-Chairman no data€124.00k0.00055%
MX$ 61.5k
Juan Carlos-Torres Carretero
Founderno datano datano data
María Luisa de Francia Caballero
Chief Financial Officer23.4yrsno datano data
José Luis Moreno Martinez-Losa
Director of Capital Markets & Investor Relations8.4yrsno datano data
Juan Pulido
General Counsel & Secretary of the Board of Directors3.8yrsno datano data
Sandra Sanchez
Global Compliance Head3.1yrsno datano data
Lara Vadillo
Communication Directorno datano datano data
Juan Nogues
Director of International Marketing & Sales10.3yrsno datano data
Belén Veramendi
Director of Corporate Development1.4yrsno datano data
Luis Cuenca
Director of Human Resources & IT19.9yrsno datano data
Luis Mora Capitan
Managing Director of Oncology & Virology Business Units16.2yrsno datano data

10.3yrs

Average Tenure

Experienced Management: PHM1 N's management team is seasoned and experienced (10.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Jose Maria Fernandez Sousa-Faro
Founderno data€294.00k6.15%
MX$ 687.5m
Pedro Fernandez Puentes
Executive Vice-Chairman no data€124.00k0.00055%
MX$ 61.5k
Eduardo Serra Rexech
Independent Other External Director2.4yrs€35.00k0.061%
MX$ 6.8m
M. Solchaga Catalan
Independent Other External Directorno data€35.00kno data
Montserrat Andrade Detrell
Proprietary Directorno data€34.00k5.27%
MX$ 589.4m
Blanca Hernandez Rodriguez
Independent Director4.4yrsno datano data
Maria Sandra Mera
Representative Proprietary Director2.5yrsno datano data
Rosa Maria Alonso
Independent Directorless than a yearno data0.0010%
MX$ 114.1k
Mariano Rodriguez
Independent Directorless than a yearno datano data
Emiliano Aller
Independent Directorless than a yearno datano data
Fernando Santos
Independent Other External Directorno datano datano data

1.7yrs

Average Tenure

Experienced Board: PHM1 N's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/06/12 16:08
End of Day Share Price 2023/03/16 00:00
Earnings2023/03/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Pharma Mar, S.A. is covered by 11 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Guilherme SampaioBanco BPI, S.A.
Patricia CifuentesBestinver Sociedad De Valores, S.A
Keay NakaeChardan Capital Markets, LLC